Genomics Biotech Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 18.18 Cr
as on 05-07-2024
- Company Age 38 years 4 months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.90 Cr
as on 05-07-2024
- Revenue %
FY 2017
- Profit -19.80%
FY 2017
- Ebitda -19.80%
FY 2017
- Net Worth -0.01%
FY 2017
- Total Assets -0.01%
FY 2017
About Genomics Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 18.18 Cr.
The Corporate currently has active open charges totaling ₹4.90 Cr.
Hem Raj, Usha Gupta, and Sachin Gupta serve as directors at the Company.
- CIN/LLPIN
U24231DL1986PLC024162
- Company No.
024162
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 May 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Genomics Biotech?
Executive Team (1)
SG
Sachin Gupta
Managing DirectorAppointment Date: 24-Dec-2004
Status: Current
Board Members(2)
Financial Performance and Corporate Structure Insights of Genomics Biotech.
Genomics Biotech Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 19.8% decrease in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genomics Biotech?
In 2017, Genomics Biotech had a promoter holding of 2.09% and a public holding of 97.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lord Krishna Infotech Limited
Active
24 years 11 months Hem Raj, Usha Gupta and 1 more are mutual person
J B A Agencies Private Limited
Active 18 years 5 months Usha Gupta and Sachin Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Bikaner & Jaipur Creation Date: 18 Dec 1996 | ₹2.29 Cr | Open |
State Bank Of Bikaner & Jaipur Creation Date: 28 Oct 1996 | ₹7.80 M | Open |
State Bank Of Bikaner & Jaipur Creation Date: 25 Oct 1989 | ₹6.50 M | Open |
How Many Employees Work at Genomics Biotech?
Unlock and access historical data on people associated with Genomics Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genomics Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomics Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
